logo

SGMO

Sangamo Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.92 / 10
Underperform

Technically, SGMO scores 1.92/10, classified as poor. Dominant bearish signals include Long Upper Shadow and MACD Death Cross, with no bullish indicators observed. Recent daily data show a cluster of negative patterns (e.g., 2026-02-02: Long Upper Shadow, RSI Overbought; 2026-02-03: Long Upper Shadow; 2026-02-05: Long Upper Shadow, MACD Death Cross), reinforcing a downtrend and highlighting the need for caution.

FundamentalSentimentTechnical(1.92)

Analysis Checks(0/5)

Long Upper Shadow
Score1/10
Win Rate32.50%
Hist. Signals80
Avg Return-2.73%
Long Lower Shadow
Score1.74/10
Win Rate44.78%
Hist. Signals67
Avg Return-0.94%
RSI Overbought
Score3.27/10
Win Rate50.00%
Hist. Signals4
Avg Return-1.20%
MACD Death Cross
Score2.58/10
Win Rate45.45%
Hist. Signals11
Avg Return-0.74%
MACD Golden Cross
Score1/10
Win Rate30.00%
Hist. Signals10
Avg Return-5.97%
What is the current technical signals for SGMO?
  • SGMO presents a Underperform setup with a Technical Score of 1.92/10. Key technical indicators highlight an RSI of 47.11 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 0.44. Traders should monitor key support at 0.34 and resistance at 0.38.